A Case of Success With Immunotherapy After Changing the Therapeutics Strategy in Non-small Cell Lung Cancer

Immune checkpoint inhibitors (ICI) have already shown benefit with higher response and survival rates when compared to standard chemotherapy in advanced non-small cell lung cancer (NSCLC). Although there is evidence that radiation and immunotherapy offer good response rates without additional toxici...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado, Bárbara, Soares de Pinho, Inês, Aranha, Ana Rita, Malyarchuck, Viktor, Godinho, Joana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679959/
https://www.ncbi.nlm.nih.gov/pubmed/38021550
http://dx.doi.org/10.7759/cureus.47874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679959/
https://www.ncbi.nlm.nih.gov/pubmed/38021550
http://dx.doi.org/10.7759/cureus.47874

Ejemplares similares